CURB-65 Score

Predicts 30-day mortality in community-acquired pneumonia (CAP) and guides the locus of care (outpatient vs inpatient vs ICU) and empirical antibiotic selection.

Total Score

/ 5

NICE / BTS Guidelines

  • Score 0-1: Low Severity
    Mortality < 3%. Suitable for home treatment (oral Amoxicillin usually first-line).
  • Score 2: Moderate Severity
    Mortality ~9%. Consider short-stay hospital admission or hospital-at-home. Dual oral therapy (e.g., Amoxicillin + Macrolide).
  • Score 3-5: High Severity
    Mortality 15-40%. Urgent hospital admission required, consider ICU if score ≥ 4. IV antibiotics (e.g., Co-amoxiclav + Clarithromycin).

Note: CRB-65 (excluding Urea) can be used in primary care where immediate blood results are unavailable. A CRB-65 of 0 is low risk.

← Back to all tools